[ad_1]
- Eli Lilly says monoclonal antibody cocktail cuts hospitalizations by 70% for patients at high risk of COVID-19USA TODAY
- Eli Lilly COVID-19 combination therapy reduces risk of death and hospitalization by 70%, company saysFox News
- Lilly says antibody combo cuts Covid deaths and hospitalizations by 70%CNBC Television
- New data shows that treatment with Lilly’s neutralizing antibodies, bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016), together reduces the risk of hospitalization and death from COVID-19 by 70%PRNewswire
- Studies extend hopes for COVID-19 antibody drugsKOMO News
- View full coverage on Google News
[ad_2]
Source link